Kosan
Navigation Links
Kosan in Medical News
Sunesis Pharmaceuticals Appoints Helen S. Kim to Board of Directors
...s currently a Director and Chief Executive Officer of privately held TRF Pharma, Inc. Previously, she was the Chief Executive Officer and President of kosan Biosciences Incorporated where she restructured and repositioned the company prior to successfully selling the company to Bristol-Myers Squibb in 2008...New Report Just Published: World Multiple Myeloma Therapeutics Market Report
...armaceuticals, Inc., Bristol-Myers Squibb Company, kosan Biosciences, Inc., Celgene Corporation, F. Hoffman...ual Agreement II-47 Bristol-Myers to Take Over kosan Biosciences II-47 Bristol and PDL BioPharma En...5 Bristol-Myers Squibb Company (USA) II-55 kosan Biosciences, Inc. (USA) II-55 Celgene Corporat...Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma
... kosan Leads Industry with Most Advanced Hsp90 Inhibitor ... HAYWARD, Calif., Jan. 3 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an... single prior course of treatment (first-relapse). kosan has completed both a Special Protocol Assessment w...Kosan Announces November 8, 2007 Conference Call and Webcast of Third Quarter 2007 Financial Results
... HAYWARD, Calif., Nov. 2 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) will ann...n dial 617.801.6888, access code: 98027185. About kosan kosan Biosciences is a biotechnology company advancing t...Kosan in Medical Technology
... HAYWARD, Calif., June 3 /PRNewswire-FirstCall/ -- kosan Biosciences
Incorporated (Nasdaq: KOSN ) today an...emedications and ease of pharmacist preparation.
kosan anticipates conducting additional studies with tan...s
trastuzumab will continue on study per protocol. kosan does not plan to
enroll additional patients in thi...
...HAYWARD, Calif., Jan. 15 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...t cancer represents a major market opportunity for kosan that we intend to pursue," said Robert G. Johnson,...hree weeks out of four weeks in repeated cycles. kosan is also testing alvespimycin delivered orally in a...
...HAYWARD, Calif., Oct. 23 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...pending on data from expanded dose cohorts. About kosan kosan Biosciences is a biotechnology company advancing t...
...AYWARD, Calif., Sept. 10 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...with reduced doses (one patient remains on study). kosan plans to continue to enroll patients at the 80 mg/...tion. Expanded Phase 1 Trial Includes Paclitaxel kosan has expanded the Phase 1 trial to add weekly dosin...
...HAYWARD, Calif., Sept. 6 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...e FDA's Special Protocol Assessment (SPA) process, kosan and the FDA have reached agreement on overall prot...-agent bortezomib. The Special Protocol Assessment kosan has completed applies to the TIME-1 trial. TIME-2,...
Kosan Announces Data Presentations at ASCO 2008 Annual Meeting
... HAYWARD, Calif., May 14 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...of the University of Pennsylvania. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
...AYWARD, Calif., April 16 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...all of the leukemia models tested. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer
...AYWARD, Calif., April 14 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...disease in many additional tumors. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at......HAYWARD, Calif., Jan. 15 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...t cancer represents a major market opportunity for kosan that we intend to pursue," said Robert G. Johnson,...hree weeks out of four weeks in repeated cycles. kosan is also testing alvespimycin delivered orally in a...
Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
... HAYWARD, Calif., Dec. 8 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...d to be progression-free survival. About Kosan kosan Biosciences is a biotechnology company advancing t...heat shock protein 90) inhibitors and epothilones. kosan is leveraging its proprietary discovery platform t......HAYWARD, Calif., Oct. 23 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...pending on data from expanded dose cohorts. About kosan kosan Biosciences is a biotechnology company advancing t...
...AYWARD, Calif., Sept. 10 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...with reduced doses (one patient remains on study). kosan plans to continue to enroll patients at the 80 mg/...tion. Expanded Phase 1 Trial Includes Paclitaxel kosan has expanded the Phase 1 trial to add weekly dosin...
...HAYWARD, Calif., Sept. 6 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...e FDA's Special Protocol Assessment (SPA) process, kosan and the FDA have reached agreement on overall prot...-agent bortezomib. The Special Protocol Assessment kosan has completed applies to the TIME-1 trial. TIME-2,...
Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
... HAYWARD, Calif., Aug. 2 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...ed primarily by the patient's level of M protein. kosan anticipates that the pivotal TIME-1 trial will beg...ion of cytotoxic proteins, leading to cell death. kosan reported data from a Phase 1b trial of tanespimyci...Kosan in Biological Technology
Proteolix Announces New Appointment in Finance and Expands Clinical and Regulatory Leadership Team
...tory bodies outside the United States. Dr. Kraus joins Proteolix from kosan Biosciences (acquired by Bristol-Myers Squibb in 2008), where he served as ...velopment strategy of Kosan's oncology product portfolio. Prior to joining kosan in 2006, he was Group Director, Global Regulatory Strategy, Oncology with B...Kosan Appoints Pamela S. Cohen, M.D., as Chief Medical Officer
... HAYWARD, Calif., May 20 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...ologist, most notably at Novartis. Dr. Cohen joins kosan from GE Healthcare Medical Diagnostics where she s... use in oncology drug development. About Kosan kosan Biosciences is a biotechnology company advancing t...Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference
... HAYWARD, Calif., May 6 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) announce...s will be available for two weeks. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...Kosan Announces May 1, 2008 Conference Call and Webcast of First Quarter 2008 Financial Results
...AYWARD, Calif., April 25 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) will ann...7-801-6888, access code: 17626068. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...Kosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACR
...AYWARD, Calif., April 16 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...ntial as a novel anticancer agent. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...Kosan Restructures Workforce to Focus Resources on Lead Clinical Programs
...AYWARD, Calif., March 18 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...high-value, near-term commercial opportunities." kosan anticipates incurring restructuring charges of app...40-$50 million to $37-$47 million. About Kosan kosan Biosciences is a biotechnology company advancing t...Kosan's Board of Directors Appoints Helen S. Kim as Chief Executive Officer
...AYWARD, Calif., March 18 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...e Officer, effectively immediately. Ms. Kim joined kosan in January 2008 as Senior Vice President and Chief...erience, demonstrated leadership and commitment to kosan to ensure that our company can operate at the high...Kosan Biosciences to Present at the Cowen and Company 28th Annual Health Care Conference
...AYWARD, Calif., March 14 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) announce...n will be available for two weeks. About Kosan kosan Biosciences is a biotechnology company advancing t...ux disease (GERD). For additional information on kosan Biosciences, please visit the company's website at......HAYWARD, Calif., Feb. 29 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) announce...s will be available for two weeks. About Kosan kosan Biosciences is a biotechnology company advancing t...ux disease (GERD). For additional information on kosan Biosciences, please visit the company's website at...
Kosan Announces Senior Management Changes and Clinical Portfolio Priorities
...HAYWARD, Calif., Feb. 28 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...san's Board of Directors. Helen S. Kim, who joined kosan in January 2008 as Senior Vice President and Chief... President of Kosan. "Under Robert's leadership, kosan made the successful transition from a research-ori...Other TagsPPIPPIPPIPPIPPIStepperOther Contentsdiverticulitisdomesticdomesticdomesticdomesticdomesticdomesticdomesticdogdogdogdogdogdroolingdouchedraindraindraindraindraindraindraindrowsinessdrowsinessdressingdressingdressing
ProgenitorsKeratinocyteSolenoidPPISCOOPROUNDEDMICROSPATULAStepperHarvesterFiltermatSCRAPERActiveSightmixturesLIFTER
(Date:11/28/2009)...Repeat offenders were more likely to consider chan...y finds , , FRIDAY, Nov. 27 (HealthDay N...rs to consider why they should stop their dangerou...g changes, researchers have found. , The new st...iving-while-impaired convictions, who were randoml...
(Date:11/27/2009)..., , BEDFORD, Mass., Nov. 27 /PRNewswire-F...he "Company"), a supplier of precision technology ...d that an annual meeting of the Company,s sharehol.... The time and location of the meeting will be an...he Company received a requisition notice from Step...
(Date:11/27/2009)..., , DALLAS, Nov. 27 /PRNewswire-USNewswire...edical procedure only 25 years ago, solid organ tr...ation thanks to the extraordinary men and women wh...n Nov. 11. Leaders came together from medical cent...sary of Baylor Regional Transplant Institute (BRTI...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 /...merican professional cycling team dedicated to eth...f cycling champions, announced today that it will ...f Transitions Optical as a new sponsor of the team...acturer of adaptive eyewear, offering the most adv...
(Date:11/27/2009)...Walking and cycling plus low-emission vehicles may... , FRIDAY, Nov. 27 (HealthDay News) -- Enc... of using cars would offer much greater public hea...ehicles, U.K. researchers have found. , The stu...f alternative urban land transport scenarios for L...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:More Foot Power, Less Car Pollution Best for Health 2[1] Drunk Drivers May Respond to Brief Motivational Interview[0] GSI Group Calls Shareholders Meeting[0] Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor[0] More Foot Power, Less Car Pollution Best for Health
(Date:11/25/2009)...niversity assistant professors recently received f...to continue research beneficial to understanding t..., Christopher Blackwood, assistant professor in t...grants to support two separate research projects. ...ecomposer Communities and Functions from the Leaf ...
(Date:11/24/2009)... years it has been prescribed by traditional heale...daches and stomach pain to fever and flu. , Now f...sity have been able to scientifically prove the pa...wise known as Brazilian mint. , Testing this anci...esearcher Graciela Rocha was able to show that whe...
(Date:11/24/2009)...s opening new doors to understanding how sounds as...of a marine mammal or if they hear it at all. , ...nners that NASA uses to detect flaws in the space ...ing scientists to peek inside the giant head of a ...nsional replicas of a whale,s hearing anatomy usin...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2Reflective film can boost profits for apple growers 10621 1Reflective film can boost profits for apple growers 10621 2Sustainably grown garlic 10616 1Sustainably grown garlic 10616 2Sustainably grown garlic 10616 3Trauma Deadlier for Kids Without Insurance 60632 1Trauma Deadlier for Kids Without Insurance 60632 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |